Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Theor Med Bioeth. 2011 Aug;32(4):229-43. doi: 10.1007/s11017-011-9179-8.

The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.

Author information

  • 1Department of Bioethics Clinical Center, National Institutes of Health, Building 10, Bethesda, MD 20892-1156, USA. fmiller@nih.gov

Abstract

It has been presumed within bioethics that the benefits and risks of treatments can be assessed independently of information disclosure to patients as part of the informed consent process. Research on placebo and nocebo effects indicates that this is not true for symptomatic treatments. The benefits and risks that patients experience from symptomatic treatments can be shaped powerfully by information about these treatments provided by clinicians. In this paper we discuss the implications of placebo and nocebo research for risk-benefit assessment and informed consent.

PMID:
21479794
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer
    Loading ...
    Write to the Help Desk